Brandinium

Trademark search for:

RANIMAB

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2018-10-05 — Application filed
  • 2018-11-01 — Sn assigned for sect 66a appl from ib
  • 2018-11-07 — Application filed
  • 2018-11-13 — Application filed
  • 2019-01-16 — Assigned to examiner
  • 2019-01-23 — Final disposition recorded
  • 2019-01-24 — Office action issued
  • 2019-02-06 — Office action issued
  • 2019-02-06 — Office action issued
  • 2019-02-22 — Office action issued
  • 2019-06-12 — Attorney/dom.rep.revoked and/or appointed
  • 2019-06-12 — Teas revoke/app/change addr of atty/dom rep received
  • 2019-06-14 — Teas/email correspondence entered
  • 2019-06-14 — Office action issued
  • 2019-06-14 — Correspondence received in law office
  • 2019-06-17 — Approved for pub - principal register
  • 2019-06-25 — Withdrawn from pub - comm.office request
  • 2019-07-03 — Examiners amendment -written
  • 2019-07-03 — Approved for pub - principal register
  • 2019-07-03 — Examiners amendment e-mailed
  • 2019-07-03 — Notification of examiners amendment e-mailed
  • 2019-07-03 — Examiner's amendment entered
  • 2019-07-03 — Previous allowance count withdrawn
  • 2019-07-15 — Assigned to lie
  • 2019-07-31 — Notification of possible opposition sent to ib
  • 2019-07-31 — Notification of notice of publication e-mailed
  • 2019-07-31 — Notice of start of opposition period created, to be sent to ib
  • 2019-08-15 — Change of owner received from ib
  • 2019-08-16 — Notification processed by ib
  • 2019-08-20 — Published for opposition
  • 2019-08-20 — Official gazette publication confirmation e-mailed
  • 2019-09-17 — Extension of time to oppose received
  • 2019-10-08 — Teas post publication amendment received
  • 2019-11-05 — Assigned to petition staff
  • 2019-11-06 — Review of correspondence complete
  • 2019-12-02 — Final status recorded
  • 2019-12-10 — Correspondence received in law office
  • 2019-12-20 — Death of international registration
  • 2019-12-21 — Notification of effect of cancellation of intl reg e-mailed
  • 2020-01-08 — Review of correspondence complete - address updated

Owner Information

Klinge Biopharma GmbH
DE
Klinge Biopharma GmbH
DE
Klinge Pharma GmbH
Holzkirchen DE

Correspondent

Charles T. J. Weigell FROSS ZELNICK LEHRMAN & ZISSU, P.C.
151 WEST 42nd St., 17 Fl.
NEW YORK, NY 10036
UNITED STATES

Filing Details

Filing Date:
2018-10-05
Status Date:
2019-12-02
Category:
Pharmaceuticals
Filing Year:
2018

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.